Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedJan 17, 2025
DataAggregated Company Financials
Companies215
  • 7D-0.6%
  • 3M-2.9%
  • 1Y3.4%
  • YTD3.1%

Over the last 7 days, the Healthcare industry has remained flat, although notably Caliway Biopharmaceuticals gained 5.3%. In line with that, the industry has also been flat over the past 12 months. Looking forward, earnings are forecast to grow by 53% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 17 Jan 2025NT$1.5tNT$245.2bNT$8.6b22.1x177.7x6.2x
Sun, 15 Dec 2024NT$1.5tNT$245.0bNT$8.6b21.9x169.3x6x
Tue, 12 Nov 2024NT$1.5tNT$238.3bNT$7.8b22.9x198x6.5x
Thu, 10 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.7x227.6x6.5x
Sat, 07 Sep 2024NT$1.6tNT$236.4bNT$6.8b25.1x232.7x6.7x
Mon, 05 Aug 2024NT$1.6tNT$229.1bNT$3.5b27.9x452.1x6.9x
Wed, 03 Jul 2024NT$1.7tNT$228.8bNT$3.6b28.9x469.3x7.4x
Fri, 31 May 2024NT$1.5tNT$228.6bNT$3.9b25.9x378x6.5x
Sun, 28 Apr 2024NT$1.4tNT$228.8bNT$4.2b25.9x337.6x6.2x
Tue, 26 Mar 2024NT$1.4tNT$228.8bNT$7.5b25.6x192.2x6.3x
Thu, 22 Feb 2024NT$1.4tNT$225.8bNT$6.5b25.6x221x6.3x
Sat, 20 Jan 2024NT$1.4tNT$224.9bNT$6.0b24.5x231.6x6.2x
Mon, 18 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.4x241.2x6.3x
Wed, 15 Nov 2023NT$1.4tNT$225.5bNT$7.5b25.1x181.2x6x
Fri, 13 Oct 2023NT$1.4tNT$225.3bNT$8.3b25.5x164.9x6x
Sun, 10 Sep 2023NT$1.4tNT$225.2bNT$8.4b25.5x163.3x6.1x
Tue, 08 Aug 2023NT$1.4tNT$226.8bNT$11.3b25.8x124.2x6.2x
Thu, 06 Jul 2023NT$1.5tNT$226.5bNT$11.6b25.8x126.2x6.4x
Sat, 03 Jun 2023NT$1.4tNT$225.5bNT$13.0b24x110.2x6.4x
Mon, 01 May 2023NT$1.4tNT$220.1bNT$12.0b23.6x120.1x6.6x
Wed, 29 Mar 2023NT$1.4tNT$219.6bNT$12.2b21.2x115x6.4x
Fri, 24 Feb 2023NT$1.5tNT$214.5bNT$13.6b21.6x106.9x6.8x
Sun, 22 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Tue, 20 Dec 2022NT$1.3tNT$214.5bNT$14.1b20.3x94.3x6.2x
Thu, 17 Nov 2022NT$1.2tNT$215.7bNT$15.5b17.5x79.6x5.7x
Sat, 15 Oct 2022NT$1.2tNT$207.4bNT$10.8b19x109.4x5.7x
Mon, 12 Sep 2022NT$1.4tNT$207.4bNT$10.7b21.6x132.4x6.9x
Wed, 10 Aug 2022NT$1.2tNT$200.4bNT$10.2b21.9x121.5x6.2x
Fri, 08 Jul 2022NT$1.2tNT$199.0bNT$9.8b21.8x121.5x6x
Sun, 05 Jun 2022NT$1.2tNT$207.9bNT$10.7b21.9x112x5.8x
Tue, 03 May 2022NT$1.2tNT$206.2bNT$12.2b23x102x6.1x
Thu, 31 Mar 2022NT$1.3tNT$202.4bNT$14.9b23.3x84.5x6.2x
Sat, 26 Feb 2022NT$1.2tNT$202.2bNT$14.2b22.5x83.1x5.8x
Mon, 24 Jan 2022NT$1.1tNT$202.1bNT$14.1b21.7x79.2x5.5x
Price to Earnings Ratio

79.2x


Total Market Cap: NT$1.1tTotal Earnings: NT$14.1bTotal Revenue: NT$202.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 175.1x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 175x.
  • The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-0.29%
Healthcare-0.62%
Healthtech2.55%
Life Sciences2.39%
Pharma0.19%
Biotech-1.09%
Medical Equipment-1.73%
Healthcare Services-2.23%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 144x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 71% over the next 5 years.
  • This is better than its past earnings growth rate of 8.8% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$665.007.6%
+NT$7.2b		241.9%PS2041.7x
6547 Medigen Vaccine BiologicsNT$47.6016.7%
+NT$2.2b		-27.2%PS24.1x
6472 Bora PharmaceuticalsNT$793.002.3%
+NT$1.9b		13.9%PE21x
6589 EirGenixNT$79.805.3%
+NT$1.2b		-16.3%PS20.9x
6932 Mercury BiopharmaceuticalNT$14.1018.0%
+NT$905.8m		-22.7%PS1033.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6932

NT$14.10

Mercury Biopharmaceutical

7D

18.0%

1Y

-22.7%

6931

NT$77.40

Qing Song HealthLtd

7D

-14.3%

1Y

-6.9%

6919

NT$665.00

Caliway Biopharmaceuticals

7D

7.6%

1Y

241.9%

6446

NT$721.00

PharmaEssentia

7D

0.3%

1Y

124.6%

6550

NT$43.40

Polaris Group

7D

-11.2%

1Y

-41.2%

Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

Jan 13
Does Polaris Group (TWSE:6550) Have A Healthy Balance Sheet?

4130

NT$25.30

Genovate Biotechnology

7D

21.3%

1Y

4.2%

6547

NT$47.60

Medigen Vaccine Biologics

7D

16.7%

1Y

-27.2%

4743

NT$79.70

Oneness Biotech

7D

-4.9%

1Y

-51.5%

4167

NT$19.75

Savior Lifetec

7D

-9.6%

1Y

-2.7%

4119

NT$84.00

SCI Pharmtech

7D

-5.1%

1Y

-10.9%

6589

NT$79.80

EirGenix

7D

5.3%

1Y

-16.3%

4114

NT$33.20

Synmosa Biopharma

7D

-4.9%

1Y

-1.6%

1795

NT$262.50

Lotus Pharmaceutical

7D

-2.8%

1Y

-9.0%

Market Cool On Lotus Pharmaceutical Co., Ltd.'s (TWSE:1795) Earnings

Dec 04
Market Cool On Lotus Pharmaceutical Co., Ltd.'s (TWSE:1795) Earnings

6472

NT$793.00

Bora Pharmaceuticals

7D

2.3%

1Y

13.9%

4123

NT$41.60

Center Laboratories

7D

-2.9%

1Y

-9.0%

6841

NT$77.10

Ever Fortune.AI

7D

10.1%

1Y

-14.6%